Platelet extracellular vesicles in COVID-19: Potential markers and makers.

J Leukoc Biol

Department of Infectious Diseases and Immunity, Centre de recherche du CHU de Québec, Québec, Québec, Canada.

Published: January 2022

Platelets and platelet extracellular vesicles (pEV) are at the crossroads of coagulation and immunity. Extracellular vesicles are messengers that not only transmit signals between cells, but also provide information about the status of their cell of origin. Thus, pEVs have potential as both biomarkers of platelet activation and contributors to pathology. Coronavirus Disease-19 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a complex disease affecting multiple organs and is characterized by a high degree of inflammation and risk of thrombosis in some patients. In this review, we introduce pEVs as valuable biomarkers in disease with a special focus on their potential as predictors of and contributors to COVID-19.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667644PMC
http://dx.doi.org/10.1002/JLB.3MIR0221-100RDOI Listing

Publication Analysis

Top Keywords

extracellular vesicles
12
platelet extracellular
8
vesicles covid-19
4
covid-19 potential
4
potential markers
4
markers makers
4
makers platelets
4
platelets platelet
4
vesicles pev
4
pev crossroads
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!